#
##
##
##
||||Page|
|---|---|---|---|
|Trustees'|annual
report|||
|Independent
examiner's
report to the trustees||||
|Statement|of financial|activities||
|Statement|of financial|position||
|Notes to the financial statements||||
##
##
|Registered|charity|name|Medical and Life|Sciences Research|Sciences Research|Fund|
|---|---|---|---|---|---|---|
|Charity registration||number|1139383||||
|Principal office|||Medical and Life|Sciences Research||Fund|
||||University
of Warwick Science Park||||
||||Barclays Venture|Centre|||
||||Sir William
Lyons|Road|||
||||Coventry||||
|The trustees|||Prof C G Dowson||||
||||Dr A Shehu||||
||||Prof C G Fink||||
||||Dr M Atkins||||
|independent|examiner||Mr K C Varney -|ACMA of Varney|Barfield 8 Co.||
||||6 Corunna
Court||||
||||Corunna
Road||||
||||Warwick||||
||||CV34 5HQ||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||Ye|ar en|ded 5 April 2|022|||
|---|---|---|---|---|---|---|---|---|---|---|
|||||||||2022||2021|
||||||||Unrestricted|Restricted|||
||||||||funcis|funds|Total funds|Total funds|
|||||||Note|||||
|Income and|endowments||||||||||
|Donations
and||legacies||||4|447,047|33,866|480,913|500,606|
|Total income|||||||447,047|33,866|480,913|500,606|
|Expenditure|||||||||||
|Expenditure|on|raising funds:|||||||||
|Investment
Expenditure
on||management
costs
charitable
activities||||5
6,7|(1,140)
(77,762)|(33,866)|(1,140)
(111,628)|(94,068)|
|Total expenditure|||||||(78,902)|(33,866)|(112,768)|(94,068)|
|Net income|and net movement||||in funds||368,145||368,145|406,538|
|Reconciliation||offunds|||||||||
|Total funds|brought
forward||||||519,518|4,811|524,329|117,791|
|Total funds|carried forward||||||887,663|4,811|892,474|524,329|
##
##
||State|ment of Financial Po|sition|||
|---|---|---|---|---|---|
|||5April 2022||||
|||2022||2021||
|||Note||||
|Fixed assets||||||
|Investments|||800,000|||
|Current assets||||||
|Cash at bank and in|hand|93,794||525,649||
|Creditors: amounts|falling due within|||||
|one year||(1,320)||(1,320)||
|Net current assets|||92,474||524,329|
|Total assets less current liabilities|||892,474||524,329|
|Net assets|||892,474||524,329|
|Funds ofthe charity||||||
|Restricted funds|||4,811||4,811|
|Unrestncted
funds|||887,663||519,518|
|Total charity funds|||892,474||524,329|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||Unrestricted|Restricted|Total Funds|
|---|---|---|---|---|---|---|---|
||||||Funds|Funds|2021|
|Donations||||||||
|Donations|received|-|charitable|purposes|482,840|16,000|498,840|
|Donations|received|-|overheads||1,766||1,766|
|Donations|received|-|gift aid|||||
||||||484,606|16,000|500,606|
##
##
##
||||Unrestricted|Total Funds|Unrestricted|Total Funds|
|---|---|---|---|---|---|---|
||||Funds|2022|Funds|2021|
|Obtaining
investment|advice||1,140|1,140|||
|Expenditure
on charitable||activities by fund type|||||
|||||Unrestricted|Restricted|Total Funds|
|||||Funds|Funds|2022|
|Cancer and cardiovascular||research|||25,866|25,866|
|Food security and agricultural|||research|22,763||22,763|
|Bacterial research||||23,838||23,838|
|Obesity research|||||||
|Educational
support||||26,686||26,686|
|Neuroscience
research|||||8,000|8,000|
|Support costs||||4,475||4,475|
|||||77,762|33,866|111,628|
|||||Unrestricted|Restricted|Total Funds|
|||||Funds|Funds|2021|
||||||E|E|
|Cancer and cardiovascular||research||12,528|16,000|28,528|
|Food security and agricultural|||research|2,000||2,000|
|Bacterial research||||6,700||6,700|
|Obesity research||||7,912||7,912|
|Educational
support
Neuroscience
research||||31,156
15,917||31,156
15,917|
|Support costs||||1,855||1,855|
|||||78,068|16,000|94,068|
##
##
##
##
##
|||||Grant funding||Total funds|Total fund|
|---|---|---|---|---|---|---|---|
|||||of activities|Support costs|2022|2021|
|Cancer and|cardiovascular|research||25,866||25,866|28,528|
|Food security and agricultural|||research|22,763||22,763|2,000|
|Bacterial research||||23,838||23,838|6,700|
|Obesity research|||||||7,912|
|Educational|support|||26,686||26,686|31,156|
|Neuroscience|research|||8,000||8,000|15,917|
|Governance|costs||||4,475|4,475|1,855|
|||||107,153|4,475|111,628|94,068|
##
##
##
|Support cost|s||||||
|---|---|---|---|---|---|---|
||||||2022|2021|
|Accountancy|fees||||1,380|1,379|
|Legal fees|||||2,639||
|Bank charges|||||99|90|
|Computer costs|||||357|386|
||||||4,475|1,855|
|Independent|examination|fees|||||
||||||2022|2021|
|Fees payable|to the independent||examiner for:||||
|Independent|examination|ofthe|financial|statements|1,320|1,320|
##
##
##
##
##
##
|Intangible|Year ended 5 April 20
assets|22|
|---|---|---|
|||Website|
|||development|
|Cost|||
|At 6 April|2021 and 5 April 2022|3,208|
|Amortisation|||
|At 6 April|2021 and 5 April 2022|3,208|
|Carrying|amount||
|At 5 April|2022||
|At 5 April|2021||
##
|Intangible
assets relate to the capitalisation
of the des
www. medicallifesciences.
org.uk
Tangible fixed assets|ign
and development
of the cha|rity's
website:|
|---|---|---|
||Equipment|Total|
|Cost|||
|At 6 April 2021 and 5 April 2022|409|409|
|Depreciation|||
|At 6 April 2021 and 5 April 2022|409|409|
|Carrying
amount|||
|At 5 April 2022|||
|At 5 April 2021|||
|Investments|||
|||Listed|
|||investments|
|Cost or valuation|||
|At 6 April 2021|||
|Additions||800,000|
|At 5 April 2022||800,000|
|Impairment|||
|At 6 April 2021 and 5 April 2022|||
|Carrying
amount|||
|At 5 April 2022||800,000|
|At 5 April 2021|||
##
##
##
##
##
##
##
|15.|Creditors: amounts|falling|due within one year|||||
|---|---|---|---|---|---|---|---|
|||||||2022|2021|
|||||||F||
||Accruals and deferred
income|||||1,320|1,320|
|16.|Analysis
of net assets between funds|||||||
|||||Unrestricted||Restricted|Total Funds|
||||||Funds|Funds|2022|
||Investments||||800,000||800,000|
||Current assets||||88,983|4,811|93,794|
||Creditors less than|1 year|||(1,320)||(1,320)|
||Net assets||||887,663|4,811|892,474|
|||||Unrestricted||Restricted|Total Funds|
||||||Funds|Funds|2021|
||Investments|||||||
||Current assets||||520,838|4,811|525,649|
||Creditors less than|1 year|||(1,320)||(1,320)|
||Net assets||||519,518|4,811|524,329|
|17.|Financial
instruments|||||||
||The carrying
amount|for each|category of financial|instrument|is as follows:|||
|||||||2022|2021|
||Financial assets measured||at fair value through|income|and expenditure|||
||Listed investments|||||800,000||
|18.|Related parties|||||||